Are Shree Ganesh Remedies Ltd latest results good or bad?

Jan 23 2026 07:17 PM IST
share
Share Via
Shree Ganesh Remedies Ltd's latest results show mixed performance, with a 22.90% sequential growth in net sales but a 6.22% year-over-year decline, and a net profit increase of 43.77% sequentially, yet a 22.62% drop compared to last year, indicating ongoing operational challenges. Overall, while there are signs of recovery, the company faces significant financial pressures and declining return metrics.
Shree Ganesh Remedies Ltd's latest financial results present a mixed picture of performance. In the most recent quarter, the company reported net sales of ₹30.32 crores, reflecting a sequential growth of 22.90% from the previous quarter. However, this figure represents a decline of 6.22% compared to the same quarter last year, indicating challenges in maintaining revenue levels year-over-year.

Net profit for the quarter stood at ₹4.96 crores, which shows a significant sequential recovery of 43.77% from the previous quarter's ₹3.45 crores. Nonetheless, this also marks a year-on-year decline of 22.62% from ₹6.41 crores in the corresponding quarter last year, highlighting ongoing profitability pressures.

Operating margins, excluding other income, were reported at 31.76%, which is an improvement from the previous quarter's 29.59% but a decline from 34.95% in the same quarter last year. This compression in margins suggests persistent cost pressures, potentially due to rising raw material costs and increased operational expenses.

The company's return on equity (ROE) has seen a decline from an average of 19.84% to 13.31%, indicating challenges in generating returns on shareholder equity. Similarly, the return on capital employed (ROCE) has decreased from 21.83% to 16.87%, further emphasizing operational efficiency concerns.

In terms of balance sheet strength, Shree Ganesh Remedies maintains a conservative debt profile with a debt-to-equity ratio of 0.03, suggesting financial stability. However, the absence of institutional interest, with negligible holdings from foreign and domestic institutional investors, raises concerns about market confidence in the company's future performance.

Overall, while there are signs of sequential recovery in certain metrics, the year-on-year declines in revenue and profitability, along with deteriorating return metrics, indicate that Shree Ganesh Remedies Ltd is facing significant operational challenges. The company has experienced an adjustment in its evaluation, reflecting these mixed operational trends and financial pressures.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News